return to the list »

publication detail

year2020
titleEfficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
journalPLoS Med.
PMID33170863
DOI10.1371/journal.pmed.1003421
ISBN1549-1676 (Electronic) - 1549-1277 (Linking)
reference17(11):e1003421
URLhttp://www.ncbi.nlm.nih.gov/pubmed/33170863
authorsSculier D
Wandeler G
Yerly S
Marinosci A
Stoeckle M
Bernasconi E
Braun DL
Vernazza P
Cavassini M
Buzzi M
Metzner KJ
Decosterd LA
Gunthard HF
Schmid P
Limacher A
Egger M
Calmy A
and the Swiss HIV Cohort Study